AE(s)	adverse effect(s)
ATC	anaplastic thyroid cancer
BP	blood pressure
CV	cardiovascular
DBP	diastolic blood pressure
DTC	differentiated thyroid cancer
EGF	epidermal growth factor
EGFR	epidermal growth factor receptor
FGFR	fibroblast growth factor receptor
FTC	follicular thyroid cancer
HCC	hepatocellular carcinoma
HTC	Hürthle cell thyroid cancer
HGF	hepatocyte growth factor
HGFR	hepatocyte growth factor receptor
MTC	medullary thyroid cancer
MKI	multikinase inhibitor
ORR	overall response rate
OS	overall survival
PTC	papillary thyroid cancer
PDGF	platelet-derived growth factor
PDGFR	platelet-derived growth factor receptor
PDTC	poorly differentiated thyroid cancer
PFS	progression-free survival
RAI	radioactive iodine
RCC	Renal clear cell carcinoma
RR-DTC	RAI refractory DTC
RTK	receptor tyrosine kinases
SBP	systolic blood pressure
TEAE	treatment-emerged adverse effect
TE-HTN	treatment-emerged hypertension
TC	thyroid cancer
TK(s)	tyrosine kinase(s)
VEGFR	vascular endothelial growth factor receptor
VEGF	vascular endothelial growth factor